Most insurers pay for CGMs when medical-necessity criteria are met, but rules differ by plan and country.
Why So Many People Ask About CGM Insurance Coverage
Continuous glucose monitors, or CGMs, track glucose levels all day and night through a small sensor on the skin. They cut down on fingersticks, show trend arrows, and send alerts when glucose rises or falls quickly. For many people with diabetes, that stream of data reshapes daily routines, sleep, driving, and mealtime decisions.
CGMs also cost real money. Sensors, transmitters, and receivers or readers add up month after month. That is why “Are CGMs Covered By Insurance?” comes up in clinic visits, online groups, and family talks so often. People want to know whether an insurer will share the cost or leave the full bill on their shoulders.
Quick Answer: Are CGMs Covered By Insurance? Basic Eligibility Rules
Across the United States, many public and private plans now pay for CGMs for people with diabetes who meet medical-necessity rules. The same question, are CGMs covered by insurance?, usually comes down to four checks: a diabetes diagnosis, current treatment, risk of dangerous highs or lows, and safe use of the device.
| Insurance Type | Typical CGM Coverage | Common Extra Requirements |
|---|---|---|
| Medicare (U.S.) | Part B pays for therapeutic CGMs and supplies when criteria are met. | Diabetes diagnosis, insulin use or serious lows, recent visit notes, user training. |
| State Medicaid | Many states pay for CGMs for at least some adults and children with diabetes. | Prior authorization, A1C or glucose history, device list limited to certain brands. |
| Employer Or Commercial Plans | Most large plans include one or more CGM brands on the formulary. | Medical need, prior authorization, preferred pharmacy or supplier rules. |
| Marketplace Plans | Coverage ranges from broad device choice to narrow options with more cost sharing. | High deductibles, brand restrictions, step therapy in some policies. |
| High Deductible Plans | CGMs may count as covered benefits but are paid out of pocket until the deductible is met. | Deductible must be reached before coinsurance kicks in; health savings account funds can help. |
| No Insurance | No direct coverage; some device makers run savings programs or patient assistance. | Income limits, time limits, and clinic paperwork are common hurdles. |
| International Plans | Many high income countries list CGMs on national formularies for certain groups. | Rules depend on local guidance, diabetes type, age, and clinic setting. |
This table gives a broad sketch, not a promise. Real bills still depend on detailed plan rules and the CGM brand.
How Medicare Handles CGM Coverage
Medicare shapes CGM access for many older adults and people with disabilities. Under current rules, therapeutic CGMs and supplies fall under Part B as durable medical equipment when criteria are met, including a diabetes diagnosis, a prescription from the treating clinician, and evidence of insulin use or serious hypoglycemia.
The official Medicare continuous glucose monitor coverage page explains that after the Part B deductible, people generally pay twenty percent of the Medicare approved amount for the device and supplies. That coinsurance still adds up, yet it usually stays well below retail prices for sensors and transmitters month after month.
Medicare rules also ask for proof that you or a caregiver can use the device safely. Clinicians document training, and some suppliers ask for a recent face to face visit before they ship sensors.
Medicaid And State Program Differences
State Medicaid programs set their own device policies within federal rules, so CGM access depends heavily on where you live. Many states now pay for CGMs for adults and children who use insulin, while some limit coverage to certain brands, age groups, or people with type 1 diabetes.
For Medicaid members, the prior authorization form matters as much as the plan handbook. Forms often ask for recent A1C results, records of hypo or hyperglycemia, and a clinician statement showing why fingerstick monitoring alone does not meet the person’s needs.
Private Insurance, Employer Plans, And Marketplace Policies
Commercial insurers often follow Medicare-style rules but adjust details for their own networks. Many employer and marketplace plans list CGM systems on their formularies, though device choice can feel narrow and deductibles or pharmacy rules can steer people toward mail order suppliers or preferred brands.
People with smaller group or individual plans sometimes face step therapy, where insurers ask members to try fingerstick monitoring or a particular CGM model first. Appeals help when that path does not fit medical needs, especially when a clinician can show serious lows or skin reactions with a prior device.
What Factors Insurers Weigh For CGM Approval
Across the many plan types, insurers tend to ask the same core questions. These items appear again and again in coverage criteria and prior authorization forms. Knowing them helps people and clinicians build a request that matches real life needs.
Diabetes Type And Treatment Regimen
Plans usually start with diagnosis. People with type 1 diabetes who use insulin several times a day almost always fit coverage criteria. Many plans now extend eligibility to people with type 2 diabetes on basal or multiple daily injections, and some include those on non insulin treatments who have serious lows.
History Of Hypoglycemia And Glucose Swings
A record of severe lows, frequent moderate lows, or wide swings in readings often helps make the case for CGM coverage. Emergency room visits, urgent care notes, ambulance runs, or repeated calls to the clinic about lows carry weight.
Ability To Use CGM Data Safely
Every plan wants assurance that the person or caregiver can use the device correctly. Clinicians document teaching on sensor insertion, calibration when needed, alarm response, and dose changes.
Real Costs: Plan Payments, Deductibles, And CGM Bills
Even when an insurer approves coverage, monthly bills still matter. CGMs blend sensors, transmitters, receivers or readers, and sometimes pump fees. Plans may treat supplies as pharmacy benefits with copays or as durable medical equipment with coinsurance after the deductible.
| Cost Term | What It Means | Effect On CGM Bills |
|---|---|---|
| Deductible | The amount you pay each year before the plan starts sharing costs. | CGM supplies may hit the deductible first, so early year bills can feel high. |
| Coinsurance | A percentage of the allowed charge that you pay after the deductible. | If CGM falls under durable equipment, coinsurance can run higher than a flat copay. |
| Copay | A fixed amount you pay for a prescription or device refill. | Some plans assign CGM sensors to a specialty tier with larger copays. |
| Out-Of-Pocket Maximum | The most you pay for covered care in a year, after which the plan pays the rest. | For people with many medical bills, CGM costs may push them toward this ceiling. |
| Prior Authorization | Approval from the insurer before it pays for a device or supply. | Missing or late paperwork can delay CGM starts or refills. |
| Formulary | The list of drugs and devices the plan prefers, often grouped by tier. | Plans may pay more for one CGM brand than for others. |
How To Check Whether Your Plan Covers A CGM
Once you understand the main pieces, the next step is a simple check of your own coverage. Search the online member portal or benefits booklet for “continuous glucose monitor,” “therapeutic CGM,” or the device brand name in both the pharmacy and durable equipment sections.
Next, call the member services number on your insurance card. Ask the representative to look up coverage for your exact CGM model. Write down what they tell you about codes, the pharmacy or supplier, prior authorization, and the price of a thirty day sensor supply.
Finally, loop in your diabetes care team. A clinician, educator, or pharmacist can help match medical needs to plan rules, suggest device brands that plans handle smoothly, and shape prior authorization forms so they match policy language around hypoglycemia and insulin use.
Appeals, Denials, And Extra Help With Access
Even strong cases sometimes meet a first denial. Appeal letters that tie real life episodes of low or high glucose to plan criteria often change the outcome, especially when clinicians send updated notes and CGM or meter reports.
Advocacy groups such as the Medicare CGM coverage FAQ from the American Diabetes Association give plain language guidance on rules and rights. Device makers also run helplines that walk people through benefits checks, prior authorization templates, and appeal steps.
For those who still cannot get coverage, manufacturers sometimes offer discount cards or patient assistance for people who meet income rules. Some clinics lend sensors for short trials so people can experience CGM data even when long term access is still in progress.
Bringing It Together: Are CGMs Covered By Insurance For You?
The phrase “Are CGMs Covered By Insurance?” sounds simple, yet the honest reply always depends on plan type, diagnosis, treatment, and paperwork. Medicare pays for therapeutic CGMs for many people with diabetes who use insulin or have serious lows. Many Medicaid programs and commercial plans move in the same direction, though device lists, cost sharing, and rules still differ from plan to plan.
A practical path blends three moves. Learn the rules for your plan type, gather records that show why a CGM fits your care, and work with your clinic and insurer until a clear answer lands in writing. Each call and appeal letter turns a broad policy question into a personal coverage decision for daily life with diabetes.